TAC Cancer Research Results

TAC, total antioxidant capacity: Click to Expand ⟱
Source:
Type:
Total antioxidant capacity (TAC) refers to the ability of a biological sample (such as blood, tissues, or food) to counteract oxidative stress by neutralizing free radicals and reactive oxygen species (ROS).

May have reduced levels in cancers.


Scientific Papers found: Click to Expand⟱
8884- MOR,    Morin Reactivates Nrf2 by Targeting Inhibition of Keap1 to Alleviate Deoxynivalenol-Induced Intestinal Oxidative Damage
- in-vivo, Nor, NA
*other↑, *other↑, *TAC↑, *SOD↑, *GPx↑, *ROS↓, *MDA↓, *Keap1↓, *NRF2↑, *Dose↝,
8445- OM,    Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: insights from serum metabolomics, network pharmacology and experimental validation
- in-vivo, Nor, NA
*ROS↓, *NO↓, *TAC↑, *PR↝, *testos?, *Weight↓,
4220- PI,    Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination
- in-vivo, AD, NA - in-vivo, MS, NA
*memory↑, *iNOS↓, *NRF2↑, *HO-1↑, *TAC↑, *TNF-α↓, *IL1β↓, *NF-kB↓, *IL10↑, *FOXP3↑, *BDNF↑, other↑,
3349- QC,    Quercetin Exerted Protective Effects in a Rat Model of Sepsis via Inhibition of Reactive Oxygen Species (ROS) and Downregulation of High Mobility Group Box 1 (HMGB1) Protein Expression
- in-vivo, Sepsis, NA
*Sepsis↓, *ROS↓, *SOD↑, *Catalase↑, *HMGB1↓, *Inflam↓, *TAC↑,
90- QC,  HYP,    Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA‑21
- in-vitro, Pca, PC3
ROS↑, cl‑Casp3↑, cl‑PARP↑, miR-21↓, PDCD4↑, TAC↑, tumCV↓, TumCI↓,
900- QC,    Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice
- in-vivo, Nor, NA
*Weight↓, *TAC∅, *ROS↑,
6054- RES,  SeNPs,    Oral Administration of Resveratrol-Selenium-Peptide Nanocomposites Alleviates Alzheimer's Disease-like Pathogenesis by Inhibiting Aβ Aggregation and Regulating Gut Microbiota
- in-vivo, AD, NA
*Dose↝, *cognitive↑, *Aβ↓, *ROS↓, *TAC↑, *GutMicro↑, *BBB↑,
104- RES,  QC,    Resveratrol and Quercetin in Combination Have Anticancer Activity in Colon Cancer Cells and Repress Oncogenic microRNA-27a
- in-vitro, Colon, HT-29
Casp3↑, PARP↑, survivin↓, miR-27a-3p↓, Sp1/3/4↓, ZBTB10↑, ROS⇅, TAC↑, tumCV↓,
3098- RES,    Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers
- Review, Var, NA
NOTCH2↓, Wnt↓, β-catenin/ZEB1↓, p‑SMAD2↓, p‑SMAD3↓, PTCH1↓, Smo↓, Gli1↓, E-cadherin↑, NOTCH⇅, TAC?, NKG2D↑, DR4↑, survivin↓, DR5↑, BAX↑, p27/CDKN1B↑, cycD1/CCND1↓, Bcl-2↓, STAT3↓, STAT5↓, JAK↓, DNAdam↑, γH2AX↑,
3014- RosA,    Rosmarinic Acid Supplementation Acts as an Effective Antioxidant for Restoring the Antioxidation/Oxidation Balance in Wistar Rats with Cadmium-Induced Toxicity
- in-vivo, Nor, NA
*antiOx↑, *Thiols↑, *GSH↑, *TAC↑, *SOD↑, *GPx↑, *Catalase↑, *ALP↓, *ALAT↓, *AST↓, *creat↓, *BUN↓, *H2O2↓, *MDA↓, *ROS↓, cardioP↑, hepatoP↑, neuroP↑, *antiAll↑,
4601- SeNPs,  AgNPs,    Antioxidant and hepatoprotective role of selenium against silver nanoparticles
- in-vivo, Nor, NA
*TAC↑, *CRP↓, *AST↓, *ALAT↓, *toxicity↓, *GSH↑, *SOD↑, *Catalase↑, *hepatoP↑,
3329- SIL,    Silymarin regulates the HIF-1 and iNOS expression in the brain and Gills of the hypoxic-reoxygenated rainbow trout (Oncorhynchus mykis)
- in-vivo, Nor, NA
*NO↓, *MDA↓, *TAC↑, *Hif1a↓, *iNOS↓,
3324- SIL,    Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage
- in-vivo, Stroke, NA
*ROS↓, *TAC↑, *NF-kB↓, *IL2↓, *NRF2↑, *HO-1↑, *neuroP↑, *Inflam↓, *NLRP3↓,
2220- SK,    Shikonin Alleviates Gentamicin-Induced Renal Injury in Rats by Targeting Renal Endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt Cascades
- in-vivo, Nor, NA
*RenoP↑, *ROS↓, *SIRT1↓, *NRF2↑, *HO-1↑, *GSH↑, *TAC↑, *SOD↑, *MDA↓, *NO↓, *iNOS↓, *NHE3↑, *PI3K↑,
9043- SP,    Spirulina inhibits hepatocellular carcinoma through activating p53 and apoptosis and suppressing oxidative stress and angiogenesis
- in-vivo, HCC, NA
Dose↝, OS↑, AFP↓, TAC↑, BAX↑, P53↑, MDA↓, VEGF↓, ROS↓, angioG↓,
9041- SP,    Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial
- Trial, Col, NA
*Dose↝, *TAC↑, *NA↝, *QoL↑,
7036- TBE,  GA,    Terminalia bellirica (Gaertn.) Roxb. Extract and Gallic Acid Attenuate LPS-Induced Inflammation and Oxidative Stress via MAPK/NF-κB and Akt/AMPK/Nrf2 Pathways
- in-vitro, Nor, THP1 - in-vitro, Nor, RAW264.7
*ROS↓, *MAPK↓, *NF-kB↓, *TAC↑, *NRF2↑, *Akt↑, *AMPK↑, *Inflam↓,
5338- TFdiG,    Isolation and antioxidant characterization of theaflavin for neuroprotective effect in mice model
- in-vivo, Nor, NA
*antiOx↑, *TOS↑, *TAC↑, *neuroP↑,
3398- TQ,  5-FU,    Impact of thymoquinone on the Nrf2/HO-1 and MAPK/NF-κB axis in mitigating 5-fluorouracil-induced acute kidney injury in vivo
- in-vivo, Nor, NA
*RenoP↑, *TAC↑, *ROS↓, *lipid-P↓, *p38↓, *MAPK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *MDA↓, *GPx↑, *GSR↑, *Catalase↑, *BUN↓, *LDH↓, *IL1β↓,
3560- TQ,    Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes
- in-vivo, AD, NA
*cognitive↑, *SOD↑, *TAC↑, *AChE↓, *MDA↓, *NO↓, *TNF-α↓, *Bcl-2↑, *Ach↑, *neuroP↑,
3571- TQ,    The Role of Thymoquinone in Inflammatory Response in Chronic Diseases
- Review, Var, NA - Review, Stroke, NA
*BioAv↓, *BioAv↑, *Inflam↓, *antiOx↑, *ROS↓, *GSH↑, *GSTs↑, *MPO↓, *NF-kB↓, *COX2/PTGS2↓, *IL1β↓, *TNF-α↓, *IFN-γ↓, *IL6↓, *cardioP↑, *lipid-P↓, *TAC↑, *RenoP↑, Apoptosis↑, TumCCA↑, TumCP↓, TumCMig↓, angioG↓, TNF-α↓, NF-kB↓, ROS↑, EMT↓, *Aβ↓, *p‑tau↓, *BACE/β-secretase↓, *TLR2↓, *TLR4↓, *MyD88↓, *IRF3↓, *eff↑, Synergy↑, DNAdam↑, *iNOS↓,
5934- TV,    Protective Effects of Natural Antioxidants on Inflammatory Bowel Disease: Thymol and Its Pharmacological Properties
- Review, Var, NA
*Inflam↓, *antiOx↑, *Bacteria↓, AntiTum↑, *toxicity∅, *IBI↑, *ZO-1↑, *OCLN↑, *COX1↑, *TLR4↓, *NF-kB↓, *TNF-α↓, *IL1β↓, *TAC↑, *NRF2↑, *GutMicro↑,
7902- VT,    Vitexin Protects Against Scopolamine-Induced Cognitive Impairment by Preserving Synaptic Integrity and Modulating Nrf2/HO-1 and NF-κB Signaling Pathways
- in-vivo, AD, NA
*Dose↝, *Learn↑, *memory↑, *AChE↓, *lipid-P↓, *TOS↓, *MDA↓, *ONOO↓, *NO↓, *NOS2↓, *TAC↑, *BDNF↑, *GDNF↑, *PSD95↑, *GFAP↓, *NF-kB↓, *COX2/PTGS2↓, *NRF2↑, *HO-1↑, *neuroP↑, *NeuroI↓,

Showing Research Papers: 51 to 73 of 73
Prev Page 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 73

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

Catalase↓, 2,   Catalase↑, 1,   GPx↑, 1,   GSH↓, 3,   Iron↝, 1,   Keap1↑, 1,   lipid-P↓, 1,   lipid-P↑, 1,   MDA↓, 1,   MDA↑, 2,   OSI↑, 1,   ROS↓, 4,   ROS↑, 10,   ROS⇅, 1,   SOD↓, 2,   SOD↑, 1,   TAC?, 1,   TAC↓, 6,   TAC↑, 3,   TOS↑, 2,   TrxR↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

MFN2↑, 1,   mtDam↑, 2,   OCR↑, 1,   OXPHOS↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ATP↑, 1,   Glycolysis↓, 1,   TCA↑, 1,   Warburg↓, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis?, 1,   Apoptosis↑, 11,   BAD↑, 1,   Bak↑, 1,   BAX↑, 4,   Bax:Bcl2↑, 2,   Bcl-2↓, 2,   Bcl-xL↓, 1,   Casp3↑, 6,   cl‑Casp3↑, 2,   cl‑Casp3⇅, 1,   Casp7↑, 2,   Casp8↑, 1,   Casp9↑, 4,   Cyt‑c↑, 3,   DR5↑, 2,   Fas↑, 1,   Ferroptosis↑, 1,   p38↑, 1,   PDCD4↑, 1,   PUMA↑, 1,   survivin↓, 3,   XIAP↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 1,   p‑Akt↓, 1,   BRAF↑, 1,   ERK↓, 1,   JAK↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 2,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 3,   mTOR↝, 1,   p‑mTOR↓, 1,   P70S6K↓, 1,   p‑P70S6K↓, 1,   PI3K↓, 2,   PTEN↓, 1,   Raf↓, 1,   Sp1/3/4↓, 1,   STAT3↓, 2,   STAT5↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

FOXO3↑, 1,   miR-21↓, 1,   miR-27a-3p↓, 1,   other↑, 1,   RUNX2↓, 1,   SOX9↓, 1,   tumCV↓, 4,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

LC3II↑, 1,   TumAuto↑, 3,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↑, 2,   P53↑, 8,   PARP↑, 1,   cl‑PARP↑, 3,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   cycD1/CCND1↓, 1,   Ki-67↓, 2,   P21↑, 2,   p27/CDKN1B↑, 2,   TumCCA↑, 7,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Gli1↓, 1,   Ki-67↓, 2,   NOTCH⇅, 1,   NOTCH2↓, 1,   PTCH1↓, 1,   Smo↓, 1,   TumCG↓, 3,   TumCP↓, 6,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

E-cadherin↑, 1,   EMT↓, 1,   LRP1↓, 1,   MMP2↓, 1,   MTA1↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   TIMP2↓, 1,   TumCI↓, 7,   TumCMig↓, 5,   TumMeta↓, 1,   β-catenin/ZEB1↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 4,   Hif1a↓, 2,   NO↓, 1,   VEGF↓, 3,   VEGF↑, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↓, 3,   MMP↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD8+↑, 1,   COX2/PTGS2↓, 4,   DR4↑, 2,   IFN-γ↑, 1,   IL1β↓, 1,   IL4↓, 1,   IL6↓, 3,   IL8↓, 2,   Imm↑, 2,   Inflam↓, 2,   NF-kB↓, 7,   PD-L1↓, 2,   PGE2↓, 1,   TLR4↓, 1,   TNF-α↓, 3,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ER-α36↓, 1,   PPARγ↝, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 1,   ChemoSen↑, 5,   Dose↝, 3,   eff↓, 2,   eff↑, 1,   eff↝, 1,   P-gp/ABCB1↓, 1,   RadioS∅, 1,   selectivity↑, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   BRAF↑, 1,   E6↓, 1,   E7↓, 1,   IL6↓, 3,   PD-L1↓, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 2,   AntiTum↑, 2,   cardioP↑, 3,   chemoP↑, 1,   hepatoP↑, 1,   motorD↑, 1,   neuroP↑, 1,   NKG2D↑, 1,   OS↑, 2,   radioP↑, 2,   RenoP↑, 1,   Risk↓, 2,   TumVol↓, 2,   TumW↓, 1,  
Total Targets: 175

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 19,   ARE↑, 1,   Catalase↓, 1,   Catalase↑, 18,   Copper↓, 1,   Fenton↓, 1,   GPx↑, 15,   GPx4↑, 2,   GSH↑, 19,   GSR↑, 2,   GSTs↓, 1,   GSTs↑, 4,   H2O2↓, 3,   HDL↑, 1,   HO-1?, 1,   HO-1↓, 1,   HO-1↑, 11,   Keap1↓, 1,   lipid-P↓, 13,   MDA?, 1,   MDA↓, 24,   MPO↓, 2,   NOX↓, 1,   NOX4↓, 1,   NQO1↑, 5,   Nrf1↑, 1,   NRF2↓, 1,   NRF2↑, 24,   ONOO↓, 1,   PCO↓, 1,   ROMO1↑, 1,   ROS?, 1,   ROS↓, 39,   ROS↑, 1,   SOD↓, 1,   SOD↑, 28,   SOD1↑, 1,   SOD2↑, 1,   TAC↑, 62,   TAC∅, 1,   TBARS↓, 2,   Thiols↑, 1,   TOS↓, 1,   TOS↑, 1,   TrxR1↑, 1,   VitC↑, 1,   VitE↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   FPN↑, 1,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mtDam↓, 1,   PGC-1α↑, 1,   TFAM↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ALAT↓, 7,   AMPK↑, 3,   ATP↑, 1,   cAMP↑, 1,   CRM↑, 2,   glucose↓, 2,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 3,   HK2↑, 1,   LDL↓, 4,   NADPH↑, 1,   PKM2↓, 1,   SCFAs↑, 1,   SIRT1↓, 1,   SIRT1↑, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 6,   BAX↓, 4,   Bcl-2↑, 6,   Casp3↓, 6,   Cyt‑c↓, 1,   Ferroptosis↓, 2,   iNOS↓, 6,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 3,   p‑CREB↑, 1,   ERK↓, 1,   JAK2↑, 1,   MAPK↓, 5,   PI3K↓, 1,   PI3K↑, 2,   PKCδ↑, 1,   PTEN↓, 2,   p‑PTEN↑, 1,   STAT3↓, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   other↑, 4,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↓, 1,   GRP78/BiP↓, 1,   HSP90↓, 1,   NQO2↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 1,   Beclin-1/ATG6↑, 1,   LC3B↑, 1,   MitoP↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Wnt↑, 1,  

Migration(tgid=13) ⓘ

Ca+2↓, 1,   LRP1↑, 1,   MMP9↑, 1,   PAI-1/SERPINE1↓, 1,   SMAD3↓, 1,   TGF-β1↓, 1,   TGF-β1↑, 1,   Vim↓, 1,   α-SMA↓, 1,   β-catenin/ZEB1↑, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

Hif1a↓, 2,   NO?, 1,   NO↓, 11,   VCAM-1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 4,   GastroP↑, 1,   GLUT4↑, 1,   IBI↑, 2,   MMP↓, 1,   MMP↑, 3,   NHE3↑, 1,   OCLN↑, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPM7↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX1↑, 1,   COX2/PTGS2↓, 4,   Eos↓, 1,   FOXP3↑, 1,   GM-CSF↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IgE↓, 1,   IL1↓, 2,   IL10↓, 1,   IL10↑, 3,   IL13↓, 1,   IL1β↓, 10,   IL2↓, 1,   IL4↓, 1,   IL4↑, 1,   IL5↓, 1,   IL6↓, 12,   IL8↓, 1,   Imm↑, 2,   Inflam↓, 23,   Inflam↑, 1,   IRF3↓, 1,   MyD88↓, 1,   NeuroI↓, 3,   NF-kB↓, 16,   NK cell↑, 1,   NLRP3↓, 2,   PGE2↓, 2,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 14,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 3,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   Ach↑, 3,   AChE↓, 6,   BDNF↑, 6,   ChAT↑, 1,   GDNF↑, 1,   PSD95↑, 2,   RELN↑, 1,   SNAP25↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   APP↓, 3,   Aβ↓, 8,   Aβ42↓, 2,   BACE/β-secretase↓, 5,   PSEN1/PS1↓, 1,   tau↓, 4,   p‑tau↓, 3,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARγ↓, 1,   PPARγ↑, 1,   PR↝, 1,   testos?, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 4,   BioAv↑, 6,   BioAv⇅, 1,   BioAv↝, 3,   ChemoSen↑, 1,   Dose?, 2,   Dose↑, 1,   Dose↝, 10,   eff↑, 8,   GSTA1↑, 2,   Half-Life↑, 1,   Half-Life↝, 1,   Synergy↑, 5,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   ALB↑, 1,   ALP↓, 1,   anemia↓, 1,   AST↓, 6,   BMD↑, 1,   BP↓, 1,   BP↝, 1,   BUN↓, 3,   creat↓, 2,   CRP↓, 4,   Ferritin↓, 1,   HemoG↑, 1,   hs-CRP↓, 1,   IL6↓, 12,   LDH↓, 2,   LDH↑, 1,   NLR↓, 1,   NOS2↓, 1,   RBC↑, 1,   TC↓, 3,   TG/TAG↓, 3,   Urea↓, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 3,   AntiArt↑, 2,   AntiCan↑, 2,   antiD↓, 1,   AntiDiabetic↑, 4,   cardioP↑, 10,   chemoP↑, 1,   cognitive↓, 1,   cognitive↑, 8,   hepatoP↑, 5,   Learn↑, 4,   memory↑, 9,   neuroP?, 1,   neuroP↑, 14,   Obesity↓, 1,   Pain↓, 1,   QoL↑, 3,   radioP↑, 1,   RenoP↑, 6,   Sleep↑, 2,   Strength↑, 1,   Stroke↓, 2,   toxicity↓, 5,   toxicity⇅, 1,   toxicity↝, 3,   toxicity∅, 1,   Weight↓, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiFungal↑, 2,   AntiP↑, 1,   AntiViral↑, 2,   Bacteria↓, 3,   GutMicro↑, 6,   Sepsis↓, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 3,  
Total Targets: 261

Scientific Paper Hit Count for: TAC, total antioxidant capacity
4 Quercetin
3 Spirulina(Arthrospira/Limnospira)
3 Flaxseed Oil
3 Hyperoside
3 Morin
3 Resveratrol
3 Thymoquinone
2 Silver-NanoParticles
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Curcumin
2 Cisplatin
2 Lactoferrin/Talactoferrin
2 Lycopene
2 Melatonin
2 Moringa oleifera
2 Selenium NanoParticles
2 Silymarin (Milk Thistle) silibinin
1 1,8-Cineole
1 Alpha-Lipoic-Acid
1 Apigenin (mainly Parsley)
1 Biochanin A
1 Boron
1 Boswellia (frankincense)
1 Black Rice, Oryza sativa
1 buckwheat sprouts
1 Caffeic acid
1 Carnosic acid
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Carvacrol
1 Chlorogenic acid
1 Cichoric acid / Chicoric acid
1 methotrexate
1 Citicoline, CDP-Choline
1 Carvone
1 Chlorella (Chlorella vulgaris)
1 Ellagic acid
1 Emodin
1 Eugenol
1 Ferulic acid
1 Vitamin D3
1 Hydrogen Gas
1 Isoliquiritigenin
1 Radiotherapy/Radiation
1 Isovitexin
1 Kaempferol
1 L-Theanine
1 Licochalcone A
1 Metformin
1 Magnetic Field Rotating
1 Magnetic Fields
1 Magnesium
1 Zinc
1 Zeolite
1 Marjoram (Origanum majorana)
1 Piperine
1 Rosmarinic acid
1 Shikonin
1 Terminalia bellirica
1 Gallic acid
1 Aflavin-3,3′-digallate
1 5-fluorouracil
1 Thymol-Thymus vulgaris
1 Vitexin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:626  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page